# Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

> **NCT01156168** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 363 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** polymorphism analysis
- **GENETIC:** protein expression analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01156168
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-05
- **Primary completion:** 2011-09-08
- **Final completion:** 2011-09-08
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2017-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156168, "Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01156168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*